The meta-analysis by Hubner et al. showed an overall superiority ratio of 0.83 (95% CI: 0.75, 0.93) for CRC associated with the MTHFR 677TT genotype, which was also in high agreement with the results of the present study [124]. This evidence concerns the gene MTHFR and colorectal carcinoma.